- Home
- INO vs DALN Comparison
INO vs DALN Comparison
Compare INO & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- DALN
- Stock Information
- Founded
- INO 1979
- DALN 1954
- Country
- INO United States
- DALN United States
- Employees
- INO N/A
- DALN N/A
- Industry
- INO Medical/Dental Instruments
- DALN Newspapers/Magazines
- Sector
- INO Health Care
- DALN Consumer Discretionary
- Exchange
- INO Nasdaq
- DALN Nasdaq
- Market Cap
- INO 69.3M
- DALN 79.8M
- IPO Year
- INO 1998
- DALN 2008
- Fundamental
- Price
- INO $2.18
- DALN $15.76
- Analyst Decision
- INO Buy
- DALN
- Analyst Count
- INO 5
- DALN 0
- Target Price
- INO $8.80
- DALN N/A
- AVG Volume (30 Days)
- INO 2.1M
- DALN 61.1K
- Earning Date
- INO 11-13-2025
- DALN 11-11-2025
- Dividend Yield
- INO N/A
- DALN N/A
- EPS Growth
- INO N/A
- DALN N/A
- EPS
- INO N/A
- DALN N/A
- Revenue
- INO $182,337.00
- DALN $121,119,000.00
- Revenue This Year
- INO N/A
- DALN N/A
- Revenue Next Year
- INO $15,960.33
- DALN N/A
- P/E Ratio
- INO N/A
- DALN N/A
- Revenue Growth
- INO N/A
- DALN N/A
- 52 Week Low
- INO $1.30
- DALN $3.66
- 52 Week High
- INO $7.00
- DALN $16.10
- Technical
- Relative Strength Index (RSI)
- INO 47.09
- DALN 70.93
- Support Level
- INO $2.33
- DALN $14.22
- Resistance Level
- INO $2.98
- DALN $15.99
- Average True Range (ATR)
- INO 0.20
- DALN 0.17
- MACD
- INO -0.07
- DALN -0.01
- Stochastic Oscillator
- INO 2.44
- DALN 87.01
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company. It operates The Dallas Morning News (dallasnews.com), Texas' newspaper. These operations generate revenue from advertising sales within the company's newspaper and digital platforms, subscriptions and retail sales of its newspaper, and commercial printing and distribution services predominantly related to national newspapers. In addition to traditional print and digital advertising, the company has a full-service agency, Medium Giant, offering businesses comprehensive, strategic, and creative marketing solutions. The company's two reportable segments are TDMN and Agency. Maximum revenue is derived from the TDMN segment, which comprises its traditional print business. The firm's customer base is concentrated in North Texas.